Regenerative Medicine Ethics, 2014 Governing Research and Knowledge Practices

This book puts the ethics, policy and politics of stem cells into context in a way that helps readers understand why past and current issues have developed the way they have and what the implications are for their work going forward. It also addresses emerging issues as the field progresses towards clinical and industrial uses.

While there is a superabundance of material on the ethics of embryo use and questions of embryonic "personhood," there is little that covers what practicing scientists and managers need to know in order to plan and execute responsible research. Furthermore, researchers funded by the NIH are required to have ethics training as a condition of the grant. As such, this book is an essential resource to all of these pre-professional students whether they plan to move into industry, government or academia.

Part I: Foresight, hindsight and peripheral vision: Navigating contemporary legal, ethical and Policy issues in Regenerative Medicine.- Contemporary dilemmas facing regenerative medicine researchers: an overview.- Characterizing International Stem Cell Research Niches.- Policies and practices to enhance multi-sectorial collaborations and commercialization of regenerative medicine.- The Patenting Landscape for Human Embryonic Stem Cells.- Repositories for Sharing Human Data in Stem Cell Research.- PART II: Research Integrity: Updates for Regenerative Medicine Researchers.- Beyond the Checkboxes: Research Integrity for Regenerative Medicine Researchers.- Protecting Human Participants in the Procurement of Materials in Regenerative Medicine Research.- Early-Stage Research: Issues in Design and Ethics.

Linda F. Hogle is Professor of Medical Social Sciences in the School of Medicine & Public Health at the University of Wisconsin-Madison and Fellow at the Wisconsin Institutes for Discovery.  Her research includes analyses of social, ethical, and legal issues in emerging cell-based and biomedical engineering technologies, as well as concepts of risk in innovative science as understood by governance bodies. She has served as an advisor to several international research consortia focusing on stem cell and regenerative medicine.

Contributors include:

Sean P. Palecek, University of Wisconsin-Madison, Department of Chemical and Biological Engineering, WI

David Schaffer, University of California-Berkeley, Department of Chemical and Biomolecular Engineering, CA

Peter W. Zandstra, University of Toronto, Institute of Biomaterials and Biomedical Engineering, ON, Canada

David B. Resnik, National Institute of Environmental Health Sciences, NC

Tania Bubela, University of Alberta, Department of Public Health Sciences, AB, Canada

Amrita Mishra, University of Alberta, Department of Public Health Sciences, AB, Canada

Debra J. H. Mathews, The Johns Hopkins University, Berman Institute of Bioethics, MD

Kevin E. Noonan, McDonnell Boehnen Hulbert & Berghoff LLP, IL

Pilar N. Ossorio, University of Wisconsin-Madison Law School, WI

Jessica von Reyn, University of Wisconsin-Madison Law School, WI

Nancy M. P. King, Wake Forest University School of Medicine, Department of Social Sciences and Health Policy, NC

Amritava Das, University of Wisconsin-Madison, Department of Chemical and Biological Engineering, WI